Related Experiment Video
Updated: Jun 2, 2026

06:15
Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Corneal invasion by hemangiosarcoma in a horse.
Toby L Pinn1, Tim Cushing, Lorie Moore Valentino
1Cornell University, College of Veterinary Medicine, Equine and Farm Animal Hospital, Ithaca, New York 14853-6401, USA. tpinndvm@gmail.com
Veterinary Ophthalmology
|April 28, 2011
Summary
A rare equine ocular hemangiosarcoma (HSA) in a 15-year-old Arabian gelding was successfully treated with lamellar keratectomy. This surgical approach achieved long-term remission, exceeding survival times of previous equine ocular HSA cases.
Area of Science:
- Veterinary Ophthalmology
- Equine Neoplasia
- Surgical Pathology
Background:
- Ocular tumors in horses can significantly impact vision and health.
- Hemangiosarcoma (HSA) is a vascular tumor rarely reported in equine ocular tissues.
- Accurate diagnosis and effective treatment strategies are crucial for favorable outcomes.
Observation:
- A 15-year-old Arabian gelding presented with a large, nonpigmented limbal mass involving 30% of the cornea.
- The mass exhibited central necrosis and serosanguinous discharge.
- Histopathology revealed features consistent with hemangiosarcoma.
Findings:
- Lamellar keratectomy successfully removed the ocular mass.
- Immunohistochemistry confirmed hemangiosarcoma, with positive staining for von Willebrand Factor and smooth muscle actin.
- Atypical cytokeratin staining was absent, ruling out squamous cell carcinoma.
- Unusual smooth muscle actin staining in perivascular cells was noted, not previously reported in equine ocular HSA.
Implications:
- Lamellar keratectomy offers a viable, less invasive treatment option for equine ocular hemangiosarcoma.
- The case demonstrates a longer survival time than previously reported for equine ocular HSA.
- Further research into the immunophenotype of equine ocular HSA may be warranted.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
